Lung Cancer
News
Afatinib Beats Chemo in EGFR-Positive Lung Cancer
Major Finding: Progression-free survival was 11.1 months with afatinib and 6.9 months with cisplatin plus pemetrexed (HR, 0.58; P = .0004).Data...
News
Adjuvant Erlotinib Benefits Patients with EGFR-Mutated NSCLC
Video
ASCO: Top Lung Cancer Studies
News
Immunotherapy Targeting PD-1 Pathway Strikes Chord Across Cancers
Major Finding: Objective responses rates were 28% in melanoma, 27% in kidney cancer, and 18% in NSCLC, with stable disease in 6%, 27%, and 7%.Data...
News
Concurrent Chemoradiotherapy Prolongs Survival for Elderly With NSCLC
Major Finding: The primary end point (overall survival) reached 22.4 months with chemoradiotherapy, significantly longer than the 16.9 months with...
News
Annual CT Lung Cancer Screening Recommended for High-Risk Smokers
Major Finding: Patients aged 55-74 years with a 30 pack-year smoking history should be offered annual low-dose CT lung cancer screening.Data...
News
Cancer Trial Groups ECOG and ACRIN Complete Merger
Reviews
Recurrent non–small-cell lung cancer in elderly patients: a case-based review of current clinical practice
Video
Targeted Therapies for Lung Cancer
News
Ex Vivo Perfusion Expands Pool of Lung Transplants
Major Finding: One-year survival was 86% in patients who received a lung transplant after optimization with normothermic ex vivo lung perfusion...